These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
510 related articles for article (PubMed ID: 31006219)
1. [Effect of apolipoprotein E genotype on magnetic resonance spectrum in amnestic mild cognitive impairment and Alzheimer's disease patients]. Zhu XQ; Zhou X; Zhao W; Zhang YM; Liu FJ; Cao J; Sun ZW Zhonghua Yi Xue Za Zhi; 2019 Apr; 99(15):1156-1161. PubMed ID: 31006219 [No Abstract] [Full Text] [Related]
2. The interaction of APOE genotype by age in amnestic mild cognitive impairment: a voxel-based morphometric study. Chen J; Shu H; Wang Z; Liu D; Shi Y; Zhang X; Zhang Z J Alzheimers Dis; 2015; 43(2):657-68. PubMed ID: 25114090 [TBL] [Abstract][Full Text] [Related]
3. Using proton magnetic resonance spectroscopy to identify mild cognitive impairment. Wang T; Xiao S; Li X; Ding B; Ling H; Chen K; Fang Y Int Psychogeriatr; 2012 Jan; 24(1):19-27. PubMed ID: 21676281 [TBL] [Abstract][Full Text] [Related]
4. (1)H-MRS asymmetry changes in the anterior and posterior cingulate gyrus in patients with mild cognitive impairment and mild Alzheimer's disease. Guo Z; Liu X; Hou H; Wei F; Chen X; Shen Y; Chen W Compr Psychiatry; 2016 Aug; 69():179-85. PubMed ID: 27423359 [TBL] [Abstract][Full Text] [Related]
5. Quantitative electroencephalography (qEEG), apolipoprotein A-I (APOA-I), and apolipoprotein epsilon 4 (APOE ɛ4) alleles for the diagnosis of mild cognitive impairment and Alzheimer's disease. Niu X; Wang Y; Zhang X; Wang Y; Shao W; Chen L; Yang Z; Peng D Neurol Sci; 2024 Feb; 45(2):547-556. PubMed ID: 37673807 [TBL] [Abstract][Full Text] [Related]
6. Neuroimaging basis in the conversion of aMCI patients with APOE-ε4 to AD: study protocol of a prospective diagnostic trial. Chen GQ; Sheng C; Li YX; Yu Y; Wang XN; Sun Y; Li HY; Li XY; Xie YY; Han Y BMC Neurol; 2016 May; 16():64. PubMed ID: 27176479 [TBL] [Abstract][Full Text] [Related]
7. APOE genotype and age modifies the correlation between cognitive status and metabolites from hippocampus by a 2D (1)H-MRS in non-demented elders. Yin Z; Wu W; Liu R; Liang X; Yu T; Chen X; Feng J; Guo A; Xie Y; Yang H; Huang M; Tian C; Zhang B; Xu Y PeerJ; 2015; 3():e1202. PubMed ID: 26401443 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of hippocampal volume and serum brain-derived neurotrophic factor as potential diagnostic markers of conversion from amnestic mild cognitive impairment to Alzheimer disease: A STROBE-compliant article. Fang Y; Du N; Xing L; Duo Y; Zheng L Medicine (Baltimore); 2019 Jul; 98(30):e16604. PubMed ID: 31348306 [TBL] [Abstract][Full Text] [Related]
9. The apolipoprotein E gene affects the three-year trajectories of compensatory neural processes in the left-lateralized hippocampal network. Ye Q; Su F; Shu H; Gong L; Xie C; Zhang Z; Bai F Brain Imaging Behav; 2017 Oct; 11(5):1446-1458. PubMed ID: 27734307 [TBL] [Abstract][Full Text] [Related]
10. The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease. Löwe LC; Gaser C; Franke K; PLoS One; 2016; 11(7):e0157514. PubMed ID: 27410431 [TBL] [Abstract][Full Text] [Related]
11. Brain metabolism assessed via proton magnetic resonance spectroscopy in patients with amnestic or vascular mild cognitive impairment. Zhu X; Cao L; Hu X; Dong Y; Wang H; Liu F; Sun Z Clin Neurol Neurosurg; 2015 Mar; 130():80-5. PubMed ID: 25590663 [TBL] [Abstract][Full Text] [Related]
12. The APOE ε4 allele is associated with increased frontally mediated neurobehavioral symptoms in amnestic MCI. Mikos AE; Piryatinsky I; Tremont G; Malloy PF Alzheimer Dis Assoc Disord; 2013; 27(2):109-15. PubMed ID: 22874659 [TBL] [Abstract][Full Text] [Related]
13. Characteristic early changes of Glu and Cho in brain regions affected by different types of subjective cognitive decline and their clinical significance. Zeng Z; He J; Yao T Medicine (Baltimore); 2023 Dec; 102(49):e36457. PubMed ID: 38065860 [TBL] [Abstract][Full Text] [Related]
14. Mild behavioral impairment in early Alzheimer's disease and its association with APOE and BDNF risk genetic polymorphisms. Matuskova V; Veverova K; Jester DJ; Matoska V; Ismail Z; Sheardova K; Horakova H; Cerman J; Laczó J; Andel R; Hort J; Vyhnalek M Alzheimers Res Ther; 2024 Jan; 16(1):21. PubMed ID: 38279143 [TBL] [Abstract][Full Text] [Related]
15. Association between DCHS2 gene and mild cognitive impairment and Alzheimer's disease in an elderly Brazilian sample. Vieira RN; Ávila R; de Paula JJ; Cintra MT; de Souza RP; Nicolato R; Malloy-Diniz L; de Miranda DM; de Moraes EN; de Marco LA; Romano-Silva MA; Bicalho MA Int J Geriatr Psychiatry; 2016 Dec; 31(12):1337-1344. PubMed ID: 26876984 [TBL] [Abstract][Full Text] [Related]
16. Structural Alteration of Medial Temporal Lobe Subfield in the Amnestic Mild Cognitive Impairment Stage of Alzheimer's Disease. He P; Qu H; Cai M; Liu W; Gu X; Ma Q Neural Plast; 2022; 2022():8461235. PubMed ID: 35111220 [TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E ε4 Specifically Modulates the Hippocampus Functional Connectivity Network in Patients With Amnestic Mild Cognitive Impairment. Zhu L; Shu H; Liu D; Guo Q; Wang Z; Zhang Z Front Aging Neurosci; 2018; 10():289. PubMed ID: 30319395 [TBL] [Abstract][Full Text] [Related]
18. APOE Genotype Effects on Intrinsic Brain Network Connectivity in Patients with Amnestic Mild Cognitive Impairment. Wang Z; Dai Z; Shu H; Liao X; Yue C; Liu D; Guo Q; He Y; Zhang Z Sci Rep; 2017 Mar; 7(1):397. PubMed ID: 28341847 [TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease. Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O; JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367 [TBL] [Abstract][Full Text] [Related]
20. Effect of APOE ε4 genotype on amyloid-β, glucose metabolism, and gray matter volume in cognitively normal individuals and amnestic mild cognitive impairment. Li W; Li R; Yan S; Zhao Z; Shan Y; Qi Z; Lu J; Eur J Neurol; 2023 Mar; 30(3):587-596. PubMed ID: 36448771 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]